93 related articles for article (PubMed ID: 17766011)
1. MIF-1 and its peptidomimetic analogs attenuate haloperidol-induced vacuous chewing movements and modulate apomorphine-induced rotational behavior in 6-hydroxydopamine-lesioned rats.
Castellano JM; Batrynchuk J; Dolbeare K; Verma V; Mann A; Skoblenick KJ; Johnson RL; Mishra RK
Peptides; 2007 Oct; 28(10):2009-15. PubMed ID: 17766011
[TBL] [Abstract][Full Text] [Related]
2. Modulation of dopaminergic neurotransmission in the 6-hydroxydopamine lesioned rotational model by peptidomimetic analogues of L-prolyl-L-leucyl-glycinamide.
Ott MC; Mishra RK; Johnson RL
Brain Res; 1996 Oct; 737(1-2):287-91. PubMed ID: 8930377
[TBL] [Abstract][Full Text] [Related]
3. Pro-Leu-glycinamide and its peptidomimetic, PAOPA, attenuate haloperidol induced vacuous chewing movements in rat: A model of human tardive dyskinesia.
Sharma S; Paladino P; Gabriele J; Saeedi H; Henry P; Chang M; Mishra RK; Johnson RL
Peptides; 2003 Feb; 24(2):313-9. PubMed ID: 12668218
[TBL] [Abstract][Full Text] [Related]
4. Modulation of dopamine receptor agonist-induced rotational behavior in 6-OHDA-lesioned rats by a peptidomimetic analogue of Pro-Leu-Gly-NH2 (PLG).
Mishra RK; Marcotte ER; Chugh A; Barlas C; Whan D; Johnson RL
Peptides; 1997; 18(8):1209-15. PubMed ID: 9396063
[TBL] [Abstract][Full Text] [Related]
5. The effects of prolyl-leucyl-glycine amide on drug-induced rotation in lesioned rats.
Smith JR; Morgan M
Gen Pharmacol; 1982; 13(3):203-7. PubMed ID: 6124481
[TBL] [Abstract][Full Text] [Related]
6. L-prolyl-l-leucyl-glycinamide and its peptidomimetic analog 3(R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum.
Ott MC; Costain WJ; Mishra RK; Johnson RL
Peptides; 2000 Feb; 21(2):301-8. PubMed ID: 10764960
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of apomorphine-induced stereotypies by naloxone and L-prolyl-L-leucyl-glycinamide.
Quock RM; Lucas TS; Hartl TJ
Pharmacol Biochem Behav; 1983 Jul; 19(1):49-52. PubMed ID: 6137836
[TBL] [Abstract][Full Text] [Related]
8. Modulatory effects of PLG and its peptidomimetics on haloperidol-induced catalepsy in rats.
Costain WJ; Buckley AT; Evans MC; Mishra RK; Johnson RL
Peptides; 1999; 20(6):761-7. PubMed ID: 10477133
[TBL] [Abstract][Full Text] [Related]
9. MSH and MIF-I in animal models of tardive dyskinesia.
Davis KL; Kastin AJ; Beilstein BA; Vento AL
Pharmacol Biochem Behav; 1980 Jul; 13(1):37-40. PubMed ID: 6105677
[TBL] [Abstract][Full Text] [Related]
10. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and dopamine receptor modulating activity of novel peptidomimetics of L-prolyl-L-leucyl-glycinamide featuring alpha,alpha-disubstituted amino acids.
Evans MC; Pradhan A; Venkatraman S; Ojala WH; Gleason WB; Mishra RK; Johnson RL
J Med Chem; 1999 Apr; 42(8):1441-7. PubMed ID: 10212130
[TBL] [Abstract][Full Text] [Related]
12. MIF-1 attenuates apomorphine stereotypies in adult rats after neonatal 6-hydroxydopamine.
Kostrzewa RM; White TG; Zadina JE; Kastin AJ
Eur J Pharmacol; 1989 Apr; 163(1):33-42. PubMed ID: 2568266
[TBL] [Abstract][Full Text] [Related]
13. Effect of acute L-Dopa pretreatment on apomorphine-induced rotational behavior in a rat model of Parkinson's disease.
Mandel RJ
Exp Neurol; 2000 Jan; 161(1):212-9. PubMed ID: 10683287
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide.
Baures PW; Ojala WH; Costain WJ; Ott MC; Pradhan A; Gleason WB; Mishra RK; Johnson RL
J Med Chem; 1997 Oct; 40(22):3594-600. PubMed ID: 9357526
[TBL] [Abstract][Full Text] [Related]
15. MIF-1 fails to modify agonist-induced oral activity in neonatal 6-OHDA-treated rats.
Gong L; Kostrzewa RM; Kalbfleisch JH
Peptides; 1993; 14(6):1159-64. PubMed ID: 7907787
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic haloperidol and clozapine on vacuous chewing and dopamine-mediated jaw movements in rats: evaluation of a revised animal model of tardive dyskinesia.
Ikeda H; Adachi K; Hasegawa M; Sato M; Hirose N; Koshikawa N; Cools AR
J Neural Transm (Vienna); 1999; 106(11-12):1205-16. PubMed ID: 10651114
[TBL] [Abstract][Full Text] [Related]
17. [Dependence of the effects of tripeptide MIF and lithium chloride on the degree of supersensitivity of dopamine receptors of the brain].
Bondarenko NA; Val'dman AV
Biull Eksp Biol Med; 1989 Aug; 108(8):196-9. PubMed ID: 2553154
[TBL] [Abstract][Full Text] [Related]
18. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA.
Lorenc-Koci E; Czarnecka A; Lenda T; Kamińska K; Konieczny J
Neurochem Int; 2013 Dec; 63(8):790-804. PubMed ID: 24090640
[TBL] [Abstract][Full Text] [Related]
19. Increased S(-)-apomorphine-induced vacuous chewing and attenuated effect of chronic haloperidol treatment in streptozotocin-induced diabetic rat.
Sumiyoshi T; Ichikawa J; Meltzer HY
Pharmacol Biochem Behav; 1997; 57(1-2):19-22. PubMed ID: 9164549
[TBL] [Abstract][Full Text] [Related]
20. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
Sindhu KM; Banerjee R; Senthilkumar KS; Saravanan KS; Raju BC; Rao JM; Mohanakumar KP
Pharmacol Biochem Behav; 2006 Jun; 84(2):321-9. PubMed ID: 16820197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
